American Oncology Network, Inc. — Operating Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/03db6fbf-3f29-418e-a071-5d7696ed433c/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2024 | $-17.4M | 2024-01-01 – 2024-12-31 | evidence 0001628280-25-015237 |
| FY 2023 | $-49.2M | 2023-01-01 – 2023-12-31 | evidence 0001839998-24-000021 |
| FY 2022 | $5.6M | 2022-01-01 – 2022-12-31 | evidence 0001140361-23-054696 |
| FY 2021 | $911.0k | 2021-01-01 – 2021-12-31 | evidence 0001140361-23-054696 |
| FY 2020 | $22.1M | 2020-01-01 – 2020-12-31 | evidence 0001140361-23-054696 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
American Oncology Network, Inc. — all facts · Revenue · Net Income